Psychotherapy: Clinical Trials

190 trials of Psychotherapy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

93 completed, 32 unknown, 22 recruiting, 15 terminated. 107 Not applicable, 38 Phase 2, 11 Phase 3, 9 Phase 4, 7 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable107Completed 57, Unknown 23, Recruiting 10, Terminated 5, Not yet recruiting 4, Active not recruiting 3, Withdrawn 3, Enrolling by invitation 2
Phase 238Completed 19, Terminated 6, Recruiting 5, Active not recruiting 3, Not yet recruiting 3, Unknown 1, Withdrawn 1
Phase 311Completed 7, Recruiting 2, Active not recruiting 1, Not yet recruiting 1
Phase 49Terminated 4, Completed 2, Active not recruiting 1, Not yet recruiting 1, Recruiting 1
Phase 17Completed 4, Not yet recruiting 2, Unknown 1

Follow Psychotherapy: new trials by email Literature Review of Psychotherapy trials Research Report on Psychotherapy

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dynamic Treatment Regimes for Opioid Use Disorder
Medication for opioid use disorder, psychotherapy - Opioid Use Disorder
Phase 2Not yet recruitingBrigham and Women's Hospital752028-07-012025-11-04
Reestablishing Normal Gut-brain Interaction in Anorexia Nervose With Normal Gut Microbiota
Psychotherapy as usual combined with single dose normal gut microbiota, Psychotherapy treatment as usual (TAU) - Anorexia Nervosa
Phase 1Not yet recruitingHaukeland University Hospital362026-12-012026-09-24
Augmenting Parent Management Training for Child Temper Outbursts Using a Digital Tool
Psychotherapy - Disruptive Behavior Disorders, Conduct Disorder
RecruitingNational Institute of Mental Health (NIMH)2002026-10-272026-10-22
Psychotherapy for Irritability in Youth: Comparing Active Treatment to Nonactive Psychoeducation Supportive Psychotherapy
Psychotherapy - Irritability, Disruptive Mood Dysregulation Disorder
RecruitingNational Institute of Mental Health (NIMH)4102026-10-272026-10-22
Psilocybin With Psychotherapy for Improving Chronic Pain in Cancer Patients Requiring Opioids
Biospecimen Collection, Functional Magnetic Resonance Imaging, Interview - Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm
Phase 2Not yet recruitingRoswell Park Cancer Institute202026-09-152026-08-12
Sibling Caregiver CMC Pilot Study
Mental health assessment and diagnosis, psychotherapy, and treatment - Children With Medical Complexity (CMC), Siblings
Not applicableNot yet recruitingThe Hospital for Sick Children632026-09-012026-08-12
Women Who Are Victims of Violence: Treatment of PTSD Through Reactivation of Traumatic Memories Using Propranolol
Propranolol, Psychotherapy - Post-Traumatic Stress Disorder, PTSD
Phase 3Not yet recruitingUniversity Hospital, Toulouse702026-09-012026-08-28
Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or Incurable Hematologic Malignancies
Psychotherapy, Psilocybin, Survey Administration - Anxiety, Depression
Phase 2Active not recruitingUniversity of Washington182026-05-192026-07-31
Modular Intervention for Depression Study
Modular Intervention for Depression Therapy (MIND Therapy), Psychotherapy as Usual (TAU) - Major Depression
Not applicableRecruitingPontificia Universidad Catolica de Chile1502026-05-012026-05-12
CARED : A Novel Rapid Treatment Paradigm for Depression
Intermittent Theta Burst Stimulation (iTBS), Transcranial Alternating Current Stimulation (tACS), Psychotherapy - Major Depressive Disorder
Not applicableRecruitingUniversity of North Carolina, Chapel Hill302026-04-142026-06-25
Healing ALS Registry Observational Study (HAROS)
Education about treatment options, Dietary Supplements: Vitamins, Minerals, Herbs, etc., Meditation, Prayer, Talk Therapy, Affirmations, Journaling, etc. - Amyotrophic Lateral Sclerosis (ALS), Motor Neuron Disease (MND)
RecruitingHealing Advocates Registry and Ministry10002026-01-262026-06-24
Ketamine-Enhanced Therapy for Individuals With Alcohol Use Disorder and Depression: A Pilot Study (KET-DUAL)
Ketamine, Cognitive Behavioural Therapy - Alcohol Use Disorder (AUD), Major Depressive Disorder (MDD)
Phase 1 / Phase 2Not yet recruitingSouth West Sydney Local Health District202025-12-102025-11-25
Does Psychotherapy Change the Gut Microbiome in Women of Child-bearing Age?
Psychotherapy - Chronic Stress
Not applicableActive not recruitingUniversity of Nebraska302025-12-012026-10-05
Development And Evaluation of An Adaptive Web-Based Intervention for COPD
Tiered whole health support for people living with COPD - COPD (Chronic Obstructive Pulmonary Disease)
Not applicableNot yet recruitingUniversity of Colorado, Denver602025-12-012025-05-08
Impact of Therapeutic Exercise Integrated With Psychotherapy and Education in Patients With Depression
Psychotherapy, Graded activity combined with exercise and education - Depression Disorder
Not applicableNot yet recruitingMarcoMateoRiera1122025-12-012025-11-28
Resolving Early Life Stress: Psychotherapy Outcomes and Neurobiology in Complex Depression
Psychotherapy - Depression - Major Depressive Disorder, Childhood Traumas
Not applicableRecruitingSt. Joseph's Healthcare Hamilton502025-10-252026-07-14
Disposition Kinetics of Dolutegravir Among People Living With HIV With Major Depression in Nigeria
Fluoxetine, Cognitive-behavioral therapy - Depression, HIV
Phase 4Not yet recruitingUniversity of Ibadan1682025-08-142025-08-08
MDMA-Assisted Psychotherapy for Treatment Resistant PTSD in Adolescents
MDMA, Psychotherapy - PTSD, Post Traumatic Stress Disorder, Adolescents
Phase 2WithdrawnUniversity of California, Los Angeles2025-07-012025-04-10
Τhe Combination of Pharmacotherapy With RECOVERYTRSGR and RECOVERYTRSBDGR.
Group A: (Clozapine, quietiapine, olanzapine, aripiprazole, zyprasidone, risperidone, asenapine, paliperidone, clopixol,anxiolytics: clonazepam, stedon, tavor antidepressants: seropram),, Group B (Pharmacotherapy and TAU) (Clozapine, quietiapine, olanzapine, aripiprazole, zyprasidone, risperidone, asenapine, paliperidone, clopixol, clonazepam, stedon, tavor, antidepressants,, Group C (Pharmacotherapy and Psychotherapy) Clozapine, quietiapine, olanzapine, aripiprazole, zyprasidone, risperidone, asenapine, paliperidone, clopixol, clonazepam, stedon, tavor, lithium, depakine - Treatment Resistant Schizophrenia, Treatment Resistant Bipolar Disorder
Phase 4Active not recruitingDr. Stavroula Rakitzi842025-06-042026-05-01
Dose Optimization of MDMA-Assisted Therapy for PTSD
Midomafetamine, Psychotherapy - Posttraumatic Stress Disorder
Phase 2RecruitingBronx VA Medical Center602025-06-032026-10-08

Showing 20 of 190. Sign in to see all of them.

Conditions studied

Depression (40)  ·  Stress Disorders, Post-Traumatic (23)  ·  Anxiety Disorders (19)  ·  Depressive Disorder, Major (18)  ·  Mental Disorders (11)  ·  Obsessive-Compulsive Disorder (10)  ·  Depressive Disorder (6)  ·  Emotional Regulation (6)  ·  Bipolar Disorder (5)  ·  Anorexia Nervosa (4)  ·  Chronic Pain (4)  ·  Fibromyalgia (4)  ·  Behavior (3)  ·  Binge-Eating Disorder (3)  ·  Generalized Anxiety Disorder (3)

Sponsors

Modum Bad (5)  ·  Resilient Pharmaceuticals (5)  ·  New York State Psychiatric Institute (4)  ·  Emory University (3)  ·  NYU Langone Health (3)  ·  National Institute of Mental Health (NIMH) (3)  ·  Ohio State University (3)  ·  University Hospital Heidelberg (3)  ·  University of California, Los Angeles (3)  ·  Brigham and Women's Hospital (2)  ·  Cybin IRL Limited (2)  ·  Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (2)  ·  Hannover Medical School (2)  ·  Haukeland University Hospital (2)  ·  Icahn School of Medicine at Mount Sinai (2)

Countries

United States (75)  ·  Canada (12)  ·  Norway (10)  ·  Germany (9)  ·  France (7)  ·  Israel (7)  ·  China (6)  ·  Spain (6)  ·  Brazil (5)  ·  Denmark (4)  ·  Italy (4)  ·  United Kingdom (4)  ·  Pakistan (3)  ·  Switzerland (3)  ·  Chile (2)

Top investigators

Antoni Font Guiteras, PhD (2)  ·  Esther Margarit de Miguel, Msc (2)  ·  Melissa A Brotman, Ph.D. (2)  ·  Ulrike Dinger-Ehrenthal, Prof. Dr. (2)  ·  Aage Indahl, Prof.Dr (1)  ·  Alan J Budney, Ph.D. (1)  ·  Alan Schatzberg, MD (1)  ·  Ali J. Zarrabi, MD (1)  ·  Amir Inamdar, MBBS, DNB, MFPM (1)  ·  Amir Inamdar, MBBS,DNB,MFPM (1)  ·  Amy Lehrner, PhD (1)  ·  Anna E Odom, Ph.D. (1)  ·  Anna Van Meter, PhD (1)  ·  Anne M Myhre, MD Phd (1)

Results publications

PMID 31065731, PMID 31572236, PMID 32500209, PMID 33884617, PMID 13688369, PMID 1438661, PMID 14639062, PMID 15315995, PMID 15608541, PMID 17135984, PMID 17135985, PMID 17135986, PMID 17135987, PMID 17135988, PMID 17135989, PMID 17450048, PMID 17907854, PMID 17909125, PMID 18030086, PMID 18164940, PMID 18291293, PMID 18391133, PMID 18974308, PMID 19465880, PMID 19723787, PMID 19877976, PMID 20215935, PMID 20396993, PMID 21041614, PMID 21674151, PMID 21865014, PMID 21943381, PMID 22065252, PMID 22116638, PMID 22123153, PMID 22273276, PMID 22401479, PMID 23132334, PMID 23357439, PMID 23357440, PMID 23588951, PMID 23594060, PMID 23656847, PMID 23760393, PMID 23809145, PMID 23971683, PMID 24239154, PMID 24337537, PMID 24462230, PMID 24550805

NIH funding

2016 (1), 2019 (1), 2025 (1), 2KL2TR001870 (1), K01DA061975 (1), K24MH122514 (1), K43TW011995 (1), P30CA138292 (1), R01CA085566 (1), R01DA023526 (1), R01DK025568 (1), R01MH069867 (1), R01MH069915 (1), R01MH073719 (1), R01MH081864 (1)